Skin Reactions Developing After Anti-Tumor Necrosis Factor Treatment: A Paradoxical Side Effect

Öznur KUTLUK, Ayşe ÜNAL ENGİNAR, Nilüfer BALCI, Bülent BÜTÜN, Cahit KAÇAR

DOI: 10.5606/ArchRheumatol.2019.6882

Issue: Volume 34 - Issue 1 - March 2019
2157 1766

The Role of Familial Mediterranean Fever Gene Mutation in Treatment of Infantile Colitis With Resistant Perianal Fistula

Maşallah BARAN, Yeliz ÇAĞAN APPAK, Pınar GARİPCİN, Yavuz DEMİRÇELİK, Emel Ebru PALA, Berk ÖZYILMAZ, Miray KARAKOYUN, Orkan ERGÜN

DOI: 10.5606/ArchRheumatol.2018.6741

Issue: Volume 33 - Issue 4 - December 2018
2517 1698

The Turkish League Against Rheumatism Recommendations for the Management of Hand Osteoarthritis Under Guidance of the Current Literature and 2018 European League Against Rheumatism Recommendations

Fikriye Figen AYHAN, İsmihan SUNAR, Ebru UMAY, Dilek KESKİN, Lale ALTAN, Fitnat DİNÇER, Tuncay DURUÖZ, Nazım KARALEZLİ, Banu KURAN, Tiraje TUNCER

DOI: 10.46497/ArchRheumatol.2020.7693

Issue: Volume 35 - Issue 3 - September 2020
5474 1705

Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry

Marco SEBASTIANI, Andreina MANFREDI, Florenzo IANNONE, Elisa GREMESE, Alessandra BORTOLUZZI, Ennio FAVALLI, Chiara BAZZANI, Fausto SALAFFI, Enrico FUSARO, Rosario FOTI, Chiara GIANNITTI, Roberto CAPORALI, Alberto CAULI, Giulia CASSONE, Giuseppe LOPALCO, Luca PETRICCA, Gianfranco FERRACCIOLI, Giovanni LAPADULA

DOI: 10.46497/ArchRheumatol.2020.7499

Issue: Volume 35 - Issue 2 - June 2020
2469 2288

Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis

Caner Feyzi DEMİR, Ferhat BALGETiR, Özlem ETHEMOĞLU, Dürdane AKSOY, Filiz AKTAŞ, Süleyman Serdar KOCA, Mehmet Fatih YETKIN, İrem TAŞCI

DOI: 10.46497/ArchRheumatol.2021.8229

Issue: Volume 36 - Issue 2 - June 2021
1125 1493

SARS-CoV-2 infection in children with rheumatic disease: Experience of a tertiary referral center

Betül Sözeri, Ferhat Demir, Sevinç Kalın, Canan Hasbal Akkuş, Enes Salı, Deniz Çakır

DOI: 10.46497/ArchRheumatol.2021.8603

Issue: Volume 36 - Issue 3 - September 2021
2021 1812

Incorporating patient preferences into osteoarthritis treatment

Yeşim Gökçe Kutsal, Sibel Eyigör, Sevilay Karahan, Rezzan Günaydın, Jale İrdesel, Merih Sarıdoğan, Pınar Borman, Aylin Sarı, Kutay Ordu Gökkaya, Vildan Binay Safer

DOI: 10.46497/ArchRheumatol.2022.8291

Issue: Volume 36 - Issue 4 - December 2021
798 1532

Biological treatment in resistant adult-onset Still’s disease: A single-center, retrospective cohort study

Seda Çolak, Emre Tekgöz, Maghrur Mammadov, Muhammet Çınar, Sedat Yılmaz

DOI: 10.46497/ArchRheumatol.2022.8669

Issue: Volume 37 - Issue 1 - March 2022
1094 1043

Evaluation of the anti-RANKL monoclonal antibody in rheumatoid arthritis rats

Dawei Lv, Xiaodong Zhao

DOI: 10.46497/ArchRheumatol.2023.9240

Issue: Volume 38 - Issue 1 - March 2023
741 827